AJP - Endo Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Endocrinol Metab 284: E281-E290, 2003; doi:10.1152/ajpendo.00332.2002
0193-1849/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (46)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lam, T. K. T.
Right arrow Articles by Giacca, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lam, T. K. T.
Right arrow Articles by Giacca, A.
Vol. 284, Issue 2, E281-E290, February 2003

Free fatty acids increase basal hepatic glucose production and induce hepatic insulin resistance at different sites

Tony K. T. Lam1, Gérald Van de Werve3, and Adria Giacca1,2

Departments of 1 Physiology and 2 Medicine, University of Toronto, Toronto, Canada M5S 1A8; and 3 Department of Nutrition, University of Montreal, Montreal, Quebec, Canada H3C 3J7

To investigate the sites of the free fatty acid (FFA) effects to increase basal hepatic glucose production and to impair hepatic insulin action, we performed 2-h and 7-h Intralipid + heparin (IH) and saline infusions in the basal fasting state and during hyperinsulinemic clamps in overnight-fasted rats. We measured endogenous glucose production (EGP), total glucose output (TGO, the flux through glucose-6-phosphatase), glucose cycling (GC, index of flux through glucokinase = TGO - EGP), hepatic glucose 6-phosphate (G-6-P) content, and hepatic glucose-6-phosphatase and glucokinase activities. Plasma FFA levels were elevated about threefold by IH. In the basal state, IH increased TGO, in vivo glucose-6-phosphatase activity (TGO/G-6-P), and EGP (P < 0.001). During the clamp compared with the basal experiments, 2-h insulin infusion increased GC and in vivo glucokinase activity (GC/TGO; P < 0.05) and suppressed EGP (P < 0.05) but failed to significantly affect TGO and in vivo glucose-6-phosphatase activity. IH decreased the ability of insulin to increase GC and in vivo glucokinase activity (P < 0.01), and at 7 h, it also decreased the ability of insulin to suppress EGP (P < 0.001). G-6-P content was comparable in all groups. In vivo glucose-6-phosphatase and glucokinase activities did not correspond to their in vitro activities as determined in liver tissue, suggesting that stable changes in enzyme activity were not responsible for the FFA effects. The data suggest that, in overnight-fasted rats, FFA increased basal EGP and induced hepatic insulin resistance at different sites. 1) FFA increased basal EGP through an increase in TGO and in vivo glucose-6-phosphatase activity, presumably due to a stimulatory allosteric effect of fatty acyl-CoA on glucose-6-phosphatase. 2) FFA induced hepatic insulin resistance (decreased the ability of insulin to suppress EGP) through an impairment of insulin's ability to increase GC and in vivo glucokinase activity, presumably due to an inhibitory allosteric effect of fatty acyl-CoA on glucokinase and/or an impairment in glucokinase translocation.

glucose-6-phosphatase; glucokinase; total glucose output; glucose cycling


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. Dasarathy, T. Kasumov, J. M. Edmison, L. L. Gruca, C. Bennett, C. Duenas, S. Marczewski, A. J. McCullough, R. W. Hanson, and S. C. Kalhan
Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion
Am J Physiol Gastrointest Liver Physiol, September 1, 2009; 297(3): G567 - G575.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Kehlenbrink, J. Tonelli, S. Koppaka, V. Chandramouli, M. Hawkins, and P. Kishore
Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production
Am J Physiol Endocrinol Metab, July 1, 2009; 297(1): E165 - E173.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Fukuda, J. E. Jones, D. Olson, J. Hill, C. E. Lee, L. Gautron, M. Choi, J. M. Zigman, B. B. Lowell, and J. K. Elmquist
Monitoring FoxO1 Localization in Chemically Identified Neurons
J. Neurosci., December 10, 2008; 28(50): 13640 - 13648.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. S. Houser, C. D. Champagne, and D. E. Crocker
Lipolysis and glycerol gluconeogenesis in simultaneously fasting and lactating northern elephant seals
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2007; 293(6): R2376 - R2381.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
E. Park, V. Wong, X. Guan, A. I Oprescu, and A. Giacca
Salicylate prevents hepatic insulin resistance caused by short-term elevation of free fatty acids in vivo
J. Endocrinol., November 1, 2007; 195(2): 323 - 331.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. D. Champagne, D. S. Houser, and D. E. Crocker
Glucose metabolism during lactation in a fasting animal, the northern elephant seal
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R1129 - R1137.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
C. Wu, S. A. Khan, L.-J. Peng, H. Li, S. G. Carmella, and A. J. Lange
Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia
Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E536 - E543.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Kishore, J. Tonelli, S. Koppaka, C. Fratila, A. Bose, D.-E. Lee, K. Reddy, and M. Hawkins
Time-Dependent Effects of Free Fatty Acids on Glucose Effectiveness in Type 2 Diabetes
Diabetes, June 1, 2006; 55(6): 1761 - 1768.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al.
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. E. Cleasby, N. Dzamko, B. D. Hegarty, G. J. Cooney, E. W. Kraegen, and J.-M. Ye
Metformin Prevents the Development of Acute Lipid-Induced Insulin Resistance in the Rat Through Altered Hepatic Signaling Mechanisms
Diabetes, December 1, 2004; 53(12): 3258 - 3266.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
V. T. Samuel, Z.-X. Liu, X. Qu, B. D. Elder, S. Bilz, D. Befroy, A. J. Romanelli, and G. I. Shulman
Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease
J. Biol. Chem., July 30, 2004; 279(31): 32345 - 32353.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Buettner, I. Ottinger, J. Scholmerich, and L. C. Bollheimer
Preserved direct hepatic insulin action in rats with diet-induced hepatic steatosis
Am J Physiol Endocrinol Metab, May 1, 2004; 286(5): E828 - E833.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Laudes, I. Barroso, J.'a. Luan, M. A. Soos, G. Yeo, A. Meirhaeghe, L. Logie, A. Vidal-Puig, A. J. Schafer, N. J. Wareham, et al.
Genetic Variants in Human Sterol Regulatory Element Binding Protein-1c in Syndromes of Severe Insulin Resistance and Type 2 Diabetes
Diabetes, March 1, 2004; 53(3): 842 - 846.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. Hawkins, J. Tonelli, P. Kishore, D. Stein, E. Ragucci, A. Gitig, and K. Reddy
Contribution of Elevated Free Fatty Acid Levels to the Lack of Glucose Effectiveness in Type 2 Diabetes
Diabetes, November 1, 2003; 52(11): 2748 - 2758.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. K. T. Lam, A. Carpentier, G. F. Lewis, G. van de Werve, I. G. Fantus, and A. Giacca
Mechanisms of the free fatty acid-induced increase in hepatic glucose production
Am J Physiol Endocrinol Metab, May 1, 2003; 284(5): E863 - E873.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online